Webinar on Immunology welcomes you to Present your research and Ideas at Bangkok,Thailand on 30th - 31st Mar 2023.
Our main motto is to unify individuals in the scholarly community and society keen on immunology to deliver their talks on the current trends and significant issues related to research and clinical trials important for the public to be shared. Immunology acquires a wide platform for Immunologists, Doctors, Researchers, Young Researchers, Business Delegates to exchange ideas and knowledge.
Our targeted audience will be Immunology Students, Scientists, Immunology Researchers, Immunology Faculty, Medical Colleges, Immunology Associations and Societies, Business Entrepreneurs, Training and Research Institutes, Manufacturing Medical Devices Companies and Pharmaceuticals.
The immune system is a host protection system that includes several biological structures and processes in a disease-protecting organism. Immunology is a diverse and growing discipline that can be defined as the study of the mechanisms of host defences involving tissues, cells and molecules. Immunologists try to understand the nature of the immune system, how the body protects itself against infection, and what happens when everything goes wrong.
The current world of immunological research has expanded considerably, and even in the current environment of highly interdisciplinary and collaborative science, future immunologists will probably need to be at least familiar with computational, structural and system biology, nanotechnology, and tissue engineering, for example. At the same time, from primarily a host defence mechanism to a fundamental homeostatic system with organism-wide physiological and clinical significance and potentially transformative biotechnological and therapeutic applications, our perspective of the immune system has gradually developed.
Oncoimmunology or Cancer Immunology is one of immunotherapy's most popular applications. The tumor microenvironment is a major aspect of cancer biology, leading to tumor initiation, tumor growth, and therapy responses. The primary focus of Cancer Immunology Researchers is to learn how the immune system works or does not work against cancer. The success of cancer immunotherapy in recent years, including monoclonal antibodies (mAbs), cancer vaccinations, adoptive cancer therapy, and immune regulation point therapy, has revolutionized conventional cancer treatment. New plan of actions for blocking immune control point regulators, overcoming immune resistance such as engineered T-cell therapy, or identifying novel tumor antigens through next-generation sequencing have now opened a new age of immunotherapy for cancer.
Autoimmune diseases arise when inherited autoimmunity progress to pathogenic autoimmunity. Genetic factors as well as environmental causes dictate this development. The global market size of Autoimmune Disease Therapeutics was $1 million in 2018 and is expected to reach $1 million by the end of 2025, with a CAGR of 2019-2025.
HIV is a category of diseases caused by human immunodeficiency virus infection. HIV weakens the immune system and impedes the ability of the body to combat disease as they destroy T cells, macrophages and dendritic cells. There is no treatment for HIV at the moment, but there are many clinical studies devoted to a cure. Developing an HIV vaccine would save millions of lives. Share your research findings on Autoimmunity and HIV to the world; this can be possible by our Global Immunology Submit.
Transplantation, the process of moving cells, tissues and organs from one location to another to replace or repair damaged or ill organs and tissues. During transplantation, the immune system plays an important role. In transplant medicine, immunological research has led to enormous advances. Nevertheless, the most formidable obstacle to successful transplantation remains immune rejection. Continued research is needed to find ways to mitigate the risk of rejection, enhance diagnosis, and sustain the transplant's long-term survival, all of which would have a significant impact on the supply of strained tissue.
Computational immunology is a research discipline that combines approaches to immunology from high-throughput genomics and bioinformatics. This usually aims to turn immunological information into computational problems, solving them by using mathematical and statistical methods and then translating the findings into definitions of immunological significance. The Immunology Conference is an excellent platform to discuss with co-researchers and students in order to know more interesting developments in this field.
Immunogenetics is the medical genetics science which explores the interaction between the immune system and genetics. This involves researching normal immunological processes and discovering genetic variations that lead to immune deficiencies, which can lead to the discovery of new immune disease therapeutic targets.
Immunogeneticist's main focus is on recognizing, characterizing, and sequencing genes coding for multiple receptors and immune response mediators. Scientists have been able to perform blood transfusions and organ transplants safely by researching immunogenetics as well as treating autoimmune diseases such as diabetes. In future, Immunogenetics will have a wide platform for young pioneers in research and the development of technologies will facilitate gene-related corrections.
In addition to being commonly used for regenerative medicine, stem cells are also considered a useful tool in cancer treatment. Stem cells have long been used to renew the immune system for patients treated with radiation or chemotherapy. Stem cells have recently been designed to bring therapeutic reagents to target tumor sites. Cancer vaccines are researched and tested for cancer treatment based on knowledge of cancer stem cells. Using in-duced pluripotent stem cells, active T cells were created to support immunotherapy for cancer. These are due to stem cell's unique characteristics, such as immunological tolerance, migration, and tissue repair. Stem cells are used as carriers for carrying drugs or therapeutic vector viruses to tumors in gene therapy for cancer treatment.
Current research reveals a wide range of ways in which stem cells are designed to fight diseases such as cancer. A breakthrough in this field was created by the recent discovery of reprogramming patient-derived cells. There is no doubt that in the future of cancer treatment, stem cell technology will play a major role.
The study of the relationship between the central nervous system (brain and spinal cord) and the immune system is Neuroimmunology. Neuroimmunology helps develop new pharmacological treatments for various neurological conditions. Neuroinflammation and neuroimmune activation have been shown to play a role in the ethology of a number of neurological disorders such as stroke, disease of Parkinson and Alzheimer, multiple sclerosis, pain and depression associated with HIV, etc.
Cognitive neuroscience becomes a very powerful way for understanding human cognition, while results can explain functional brain structure, such as operations undertaken by a certain brain area and the network of decentralized, distinct neutral area that support a particular psychological representation. Here is a scientific meeting your new challenges at Immunology Symposium.
Tumors that affect the blood, bone marrow , lungs, and lymph system are haematopoietic or lymphoid malignancies. Hematopoietic and lymphoid tissue malignancies include leukaemias, myeloproliferative neoplasms, dyscrasia of plasma cells, and neoplasms of dendritic cells.
The immune system takes on a double job malignant growth: it counteracts the outgrowth of tumor cells and also shapes the tumor cells immunogenicity. Cells of the disease can defeat the immune system by preventing the activation of T lymphocytes.
In order to focus on these T lymphocyte induction modulators, new immunotherapies have been created. The immune checkpoints, defined as immune system atoms that either turn a flag up or turn a flag down. Through representing T cell function, the vast majority of malignancies protect themselves from the immune system. According to the current research report, an expansion in the interest of profitable is the most essential driver of the market.
Hashimoto's thyroiditis, also called Hashimoto's syndrome, is an autoimmune disease, a disorder in which the immune system switches against the body's own tissues. For people with Hashimoto, the thyroid is damaged by the immune system. AITD can be considered the most common endocrine autoimmune disease. The clinical entities found in AITDs are diverse and vary depending on whether there is predominance in the patient of a state of hypothyroidism (HT), hyperthyroidism (GD), or both painless thyroiditis (PT), postpartum thyroiditis (PPT), and sub-acute thyroiditis (SAT). There is a need for an international consensus to diagnose AITD accurately.
Among these patients, regular CVD screening should be considered. These findings may help further the study of AD's common mechanisms, improve patient satisfaction, and identify public health policies, especially for patients with RA. The current trend and future aspects can be learned and shared by our Immunology Workshop.
Allergies, also known as allergic diseases, are a number of conditions attributable to the hypersensitivity of the immune system triggered by typically harmless factors in the environment. The division has active research programs based on laboratory and clinical research and publishes more than 50 scientific papers per year. The research programs concentrate on inner-city asthma, the role of allergy sensitivity to the environment in allergic disease, the natural history of food allergy, food allergy treatment, and immune dysfunction pathogenesis in ataxia telangiectasia. In this decade, there is a real cure on the horizon.
The development of vaccines against more complex infections such as tuberculosis, malaria and aids has been challenging and has been modest to date. The final success of these infections that involve multiple vaccines, each of which activates a different arm of the immune system. In the longer term, many non-infectious diseases are likely to be used to stop or modulate the course. Therapeutic cancer vaccines have already made progress, and potential future targets include obesity, diabetes, asthma, and Alzheimer's disease.
Advances in immunodiagnostic technologies provide the foundation for the design of antigen detection platforms capable of meeting strict tolerance, specificity, rate of assay, robustness and simplicity requirements.. Emerging technologies broaden our understanding of the human immune system, but capitalizing on its development would probably require theoretical and functional changes in the way research is conducted.
08th Mar 2023
15th Mar 2023
30th - 31st Mar 2023